Today: 21 May 2026
Browse Category

NYSE:UNH 5 March 2026 - 19 May 2026

Buffett heir makes first big Berkshire shake-up: Delta joins, UnitedHealth gone

Buffett heir makes first big Berkshire shake-up: Delta joins, UnitedHealth gone

Berkshire Hathaway disclosed a new $2.65 billion stake in Delta Air Lines and sharply increased its Alphabet holdings in its first-quarter filing under CEO Greg Abel. The company exited UnitedHealth, Amazon, Visa, and Mastercard. UnitedHealth shares fell over 2% Monday after Berkshire’s exit. Berkshire’s U.S.-listed equity portfolio stood at $263.1 billion as of March 31.
UnitedHealth Falls Premarket as Berkshire Sells Stake

UnitedHealth Falls Premarket as Berkshire Sells Stake

UnitedHealth shares dropped 4.8% to $375.06 in early premarket trading Monday after Berkshire Hathaway disclosed it sold its stake in the insurer. The move follows UnitedHealth’s recent rally to near a 52-week high and comes ahead of the NYSE core session. Berkshire’s sale was part of a broader first-quarter portfolio reshuffle. UnitedHealth closed Friday at $393.85.
18 May 2026
UnitedHealth Stock Watches Berkshire Exit, Optum AI Effort

UnitedHealth Stock Watches Berkshire Exit, Optum AI Effort

Berkshire Hathaway sold its entire UnitedHealth Group stake in the first quarter, less than a year after buying 5.04 million shares. UnitedHealth shares closed at $393.85 Friday, down 1.3%. Bloomberg reported UnitedHealth is tracking some Optum workers’ use of AI tools as it expands technology in operations. Analysts say insurers need another quarter of clean medical-cost data before judging recovery.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Humana shares surged 11.27% to $274.96 on Friday, following CVS’s raised 2026 profit outlook tied to improved medical-cost control. Humana’s own 2026 forecast remains under pressure from lower Medicare Star Ratings and limited funding. First-quarter revenue rose to $39.65 billion, but adjusted earnings fell to $10.31 per share. The company maintained its full-year adjusted earnings forecast at at least $9 a share.
UnitedHealth Stock Is Climbing Again: The Medical-Cost Bet Driving UNH Shares

UnitedHealth Stock Is Climbing Again: The Medical-Cost Bet Driving UNH Shares

UnitedHealth shares rose 2.8% to $379.98 on Friday, marking a third straight gain as investors responded to signs of easing medical-cost pressure. The company reported Q1 revenue of $111.7 billion and raised its full-year adjusted earnings outlook to over $18.25 a share. UnitedHealthcare also announced it will cut prior authorization requirements for 30% of services by the end of 2026. Humana and CVS shares also climbed sharply.
Dow Jones Today: Blue-Chip Index Barely Rises as AI Rally Sends Nasdaq, S&P 500 to Records

Dow Jones Today: Blue-Chip Index Barely Rises as AI Rally Sends Nasdaq, S&P 500 to Records

The Dow Jones Industrial Average closed nearly flat Friday, up 0.02% to 49,609.16, while the S&P 500 rose 0.84% and the Nasdaq jumped 1.71% as tech shares outperformed. U.S. nonfarm payrolls increased by 115,000 in April and unemployment held at 4.3%. Nvidia gained 1.8%, and Micron and Sandisk surged about 12%. Consumer sentiment fell in May, with inflation expectations easing slightly.
UNH Stock Moves Higher as UnitedHealth Cuts Prior Approval Rules and CVS Adds Cost Signal

UNH Stock Moves Higher as UnitedHealth Cuts Prior Approval Rules and CVS Adds Cost Signal

UnitedHealthcare will cut prior authorization requirements for 30% of remaining services by the end of 2026, including some outpatient surgeries and diagnostic tests. UnitedHealth Group shares rose about 1% to $367.55 Wednesday after the announcement. The company said prior authorization now applies to just 2% of its services. Investors are watching whether insurers can reduce paperwork without losing control of costs.
SCHD vs DGRO vs VIG: The May 2026 Dividend ETF Fight Investors Are Watching

SCHD vs DGRO vs VIG: The May 2026 Dividend ETF Fight Investors Are Watching

U.S. dividend income funds drew $24.1 billion in first-quarter inflows, the strongest in four years, according to LSEG Lipper. In Monday morning trading, Schwab U.S. Dividend Equity ETF fell to $31.63, iShares Core Dividend Growth ETF slipped to $73.24, and Vanguard Dividend Appreciation ETF traded at $228.04. Investors weighed income, cost, and growth as ETF assets continued to rise.
UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Group shares rose about 4% Tuesday after Centene raised its profit forecast, fueling optimism that medical-cost pressures may be easing for large insurers. UnitedHealth last week lifted its 2026 profit outlook and reported a first-quarter medical care ratio of 83.9%. Centene’s medical loss ratio came in below analyst estimates. UnitedHealth’s Optum unit continues to face cost and contract challenges.
Schwab’s SCHD Dividend ETF Is Near $31 — Why Investors Are Choosing It Over VOO Now

Schwab’s SCHD Dividend ETF Is Near $31 — Why Investors Are Choosing It Over VOO Now

Schwab U.S. Dividend Equity ETF (SCHD) held $88.3 billion in net assets as of April 24, with a 3.34% 30-day SEC yield and 0.060% expense ratio. Vanguard’s S&P 500 ETF (VOO) offered a lower 1.16% yield and 0.03% expense ratio. SCHD’s top holdings included Texas Instruments, UnitedHealth, and Chevron. SCHD traded near its 52-week high above $31 on Monday.
US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings

US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings

U.S. stocks fell Tuesday, with the S&P 500, Nasdaq, and Dow all down about 0.6% as early gains reversed. Brent crude jumped 3.1% to $98.48 on uncertainty over U.S.-Iran talks. UnitedHealth rose 7% after strong earnings, while Apple slipped on CEO transition news. The 10-year Treasury yield climbed as investors weighed retail sales and Fed leadership signals.
US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

The S&P 500 fell 0.32% to 7,086.48 Tuesday afternoon as rising oil prices and Treasury yields erased early gains. Brent crude climbed again after a 5.6% jump Monday, following U.S.-Iran ceasefire tensions. UnitedHealth raised its full-year outlook, and Amazon pledged up to $25 billion in Anthropic. March retail sales rose 1.7%, the biggest increase in a year.
US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

U.S. stock index futures rose early Tuesday, with Nasdaq 100 futures up 0.3% and Dow futures gaining 61 points, as investors weighed AI gains against Middle East tensions. Amazon announced up to $25 billion in new investment in Anthropic, while Apple said Tim Cook will step down as CEO in September, succeeded by John Ternus. The U.S. Census Bureau will release March retail sales data at 8:30 a.m. EDT.
UnitedHealth Stock Gets Lift Ahead of Q1 Earnings After Medicare Advantage Rate Boost

UnitedHealth Stock Gets Lift Ahead of Q1 Earnings After Medicare Advantage Rate Boost

U.S. officials approved a 2.48% increase in 2027 Medicare Advantage rates Monday, sending UnitedHealth Group shares higher after months of pressure. The move adds over $13 billion to plan payments, exceeding analyst expectations. UnitedHealth reports first-quarter results April 21, with analysts forecasting an 8% earnings drop from last year. CMS kept tighter risk-adjustment rules despite the higher rates.
SCHD Draws Fresh Attention After New Dividend and 2026 Reconstitution

SCHD Draws Fresh Attention After New Dividend and 2026 Reconstitution

Schwab U.S. Dividend Equity ETF paid a $0.2569 per-share dividend for March, up 3.3% from last year, and finished a major reshuffle in its annual index reset. SCHD drew $4 billion in Q1 inflows as U.S. dividend funds saw their strongest start since 2020. The fund now holds 104 stocks, with Chevron and ConocoPhillips still its largest positions. Health care and tech exposure rose, while energy and materials fell.
SCHD ETF Rebalance Adds Abbott, UnitedHealth as Dividend Fund Inflows Hit 4-Year High

SCHD ETF Rebalance Adds Abbott, UnitedHealth as Dividend Fund Inflows Hit 4-Year High

Schwab’s U.S. Dividend Equity ETF (SCHD) increased health care holdings to 18.5% in its annual rebalance, adding Abbott Laboratories and UnitedHealth Group near the top at about 3.8% each. SCHD attracted $4 billion in Q1 as U.S. dividend funds pulled in $24.1 billion, the highest first-quarter inflow in four years. SCHD closed at $30.48 Monday, up 0.13%.
UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Group shares dropped over 4% Friday to $257.04, deepening losses after a 1.6% fall earlier in the week. Humana, Elevance, and Cigna also declined, while the Health Care Select Sector SPDR ETF slipped 1.5%. Analysts expect UnitedHealth’s first-quarter profit to fall 8.1% from last year, with investors focused on April 21 results for signs of easing medical costs.
1 2 3 10

Stock Market Today

  • Options Traders Anticipate Significant Move in Amalgamated Financial Stock
    May 21, 2026, 10:19 AM EDT. Options market activity in Amalgamated Financial Corp. (AMAL) highlights elevated implied volatility on the May 16, 2025 $22.50 call option, signaling expectations of a major stock price movement. Implied volatility reflects anticipated market fluctuation; high levels suggest investor anticipation of a strong rally or sell-off. Despite this, Amalgamated Financial holds a modest Zacks Rank #3 (Hold) status with a neutral earnings forecast slightly lowered from 91 to 90 cents per share. Analysts have not upgraded estimates recently, dampening fundamental outlook. Some options traders may leverage high implied volatility to sell premium, speculating the stock's movement will be less extreme than forecast. The divergence between options market speculation and analyst outlook invites close attention to AMAL shares in coming months.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
Go toTop